Is it time to ban sulfonylureas?
- PMID: 32767650
- DOI: 10.1111/1753-0407.13095
Is it time to ban sulfonylureas?
Similar articles
-
Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part II--"The cons".Horm Metab Res. 1996 Sep;28(9):522-6. doi: 10.1055/s-2007-979845. Horm Metab Res. 1996. PMID: 8911991 Review.
-
A Verdict for Glimepiride: Effective and Not Guilty of Cardiovascular Harm.Diabetes Care. 2019 Dec;42(12):2161-2163. doi: 10.2337/dci19-0034. Diabetes Care. 2019. PMID: 31748210 No abstract available.
-
[Clinical efficacy of glimepiride].Nihon Rinsho. 1997 Nov;55 Suppl:152-7. Nihon Rinsho. 1997. PMID: 9434460 Review. Japanese. No abstract available.
-
Controversy about the relationship between sulfonylurea use and cardiovascular events and mortality.J Diabetes Investig. 2016 Sep;7(5):674-6. doi: 10.1111/jdi.12494. Epub 2016 Mar 24. J Diabetes Investig. 2016. PMID: 27181105 Free PMC article.
-
Does mortality risk vary among sulfonylureas?Lancet Diabetes Endocrinol. 2015 Jan;3(1):6-7. doi: 10.1016/S2213-8587(14)70217-7. Epub 2014 Oct 22. Lancet Diabetes Endocrinol. 2015. PMID: 25466240 No abstract available.
Cited by
-
Effects of Danggui Buxue decoction on host gut microbiota and metabolism in GK rats with type 2 diabetes.Front Microbiol. 2022 Oct 24;13:1029409. doi: 10.3389/fmicb.2022.1029409. eCollection 2022. Front Microbiol. 2022. PMID: 36353458 Free PMC article.
References
REFERENCES
-
- Phung OJ, Scholle JM, Talwar M, Coleman CI. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA. 2010;303(14):1410-1418.
-
- Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363(15):1410-1418.
-
- Pratipanawatr T, Satirapoj B, Ongphiphadhanakul B, Suwanwalaikorn S, Nitiyanant W. Impact of hypoglycemia on health-related quality of life among type 2 diabetes: a cross-sectional study in Thailand. J Diabetes Res. 2019;2019:5903820.
-
- Ying DG, Ko SH, Li YC, Chen CX. Association between intensive glycemic control and mortality in elderly diabetic patients in the primary care: a retrospective cohort study. Prim Care Diabetes. 2020 Apr 11;S1751-9918(19)30442-5. https://doi.org/10.1016/j.pcd.2020.02.012
-
- Rao AD, Kuhadiya N, Reynolds K, Fonseca VA. Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies. Diabetes Care. 2008;31(8):1672-1678.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical